论文部分内容阅读
局限于鼻腔和鼻窦的鼻神经胶质瘤(ESB)13例,作者分成颅面联合手术切除组(CF,G_2)与术前放疗加颅外径路手术切除组(REN,G_1)进行疗效比较,并对ESB提出新的分期方法。文中介绍ESB用TNM分期方法为:T_1肿瘤在鼻腔或已侵袭邻近鼻窦(蝶窦除外),有或无前颅窝骨质破坏;T_2肿瘤累及眶周组织或侵入前颅窝;T_3肿瘤侵及脑,可切除且有安全缘;T_4肿瘤不能切除。N淋巴结受累及。M远处转移。疗效比较:G_1为1972～1977年中5例,均为T_1N_0M_0肿瘤。随访2年内3例局部复发,1例转移。G_2为1977～1989年中9例,均为T_1N_0M_0,5例随访6～9年;2例在3年以上;1例1
In 13 cases of nasal glioma (ESB) confined to the nasal cavity and paranasal sinuses, the authors divided the craniofacial combined resection group (CF, G 2) and the preoperative radiotherapy plus cranial ulna tract surgical resection group (REN, G_1) for comparison. And put forward a new method of staging ESB. This article describes the use of TNM staging method for ESB: T_1 tumor in the nasal cavity or invaded adjacent sinuses (except sphenoid sinus), with or without destruction of the anterior cranial fossa; T_2 tumors involving the periorbital tissue or invade the anterior fossa; T_3 tumor invasion The brain is resectable and safe; T_4 tumors cannot be removed. N lymph nodes involved. M distant transfer. Comparison of curative effects: G1 was 5 cases from 1972 to 1977, and both were T_1N_0M_0 tumors. Within 2 years of follow-up, 3 patients had local recurrence and 1 patient had metastasis. Nine cases of G2 from 1977 to 1989 were T_1N_0M_0, 5 cases were followed up for 6 to 9 years; 2 cases were more than 3 years; 1 case 1